This is a Validated Antibody Database (VAD) review about dog ERBB2, based on 18 published articles (read how Labome selects the articles), using ERBB2 antibody in all methods. It is aimed to help Labome visitors find the most suited ERBB2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ERBB2 synonym: HER-2; c-erbB-2; p185erbB2; receptor tyrosine-protein kinase erbB-2; proto-oncogene c-ErbB-2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog

Invitrogen
mouse monoclonal (CB11)
  • immunocytochemistry; human; loading ...; fig 1d
  • western blot; human; loading ...; fig 1b
In order to explore how HER2 signaling contributes to the formation and maintenance of membrane protrusions, Invitrogen ERBB2 antibody (Thermo Scientific, MA1-35720) was used in immunocytochemistry on human samples (fig 1d) and in western blot on human samples (fig 1b). PLoS ONE (2017) ncbi
mouse monoclonal (CB11)
  • immunoprecipitation; human; loading ...; fig 2j
  • immunocytochemistry; human; loading ...; fig 2b
  • immunohistochemistry; human; loading ...; fig 1d
  • western blot; human; loading ...; fig 2j
  • immunohistochemistry; mouse; loading ...; fig 1b
In order to show that NHERF1 and PMCA2 modulate HER2 signaling and membrane retention in breast cancers, Invitrogen ERBB2 antibody (Thermo Scientific, MA1-35720) was used in immunoprecipitation on human samples (fig 2j), in immunocytochemistry on human samples (fig 2b), in immunohistochemistry on human samples (fig 1d), in western blot on human samples (fig 2j) and in immunohistochemistry on mouse samples (fig 1b). J Biol Chem (2017) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry - paraffin section; cat; 1:200; loading ...; tbl 3
In order to develop an assay to measure serum HER2 in order to diagnose cats with mammary carcinomas, Invitrogen ERBB2 antibody (Invitrogen, CB11) was used in immunohistochemistry - paraffin section on cat samples at 1:200 (tbl 3). Oncotarget (2016) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to characterize and present the first case of fibroblastic reticular cell tumor of the breast, Invitrogen ERBB2 antibody (Thermo Fisher, CB11) was used in immunohistochemistry - paraffin section on human samples at 1:50. Exp Ther Med (2016) ncbi
mouse monoclonal (CB11)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to study the interactions between PMCA2 and HER2 in breast cancer cells, Invitrogen ERBB2 antibody (Thermo Scientific, MA1-35720) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry; human; 1:100; fig 1
In order to characterize human molecular apocrine breast cancer samples, Invitrogen ERBB2 antibody (Invitrogen, CB11) was used in immunohistochemistry on human samples at 1:100 (fig 1). Tumour Biol (2016) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry; cat; 1:200; loading ...; fig 1c
In order to describe the clinical, pathological, and immunophenotypic features collected from 61 queens with feline mammary carcinoma, Invitrogen ERBB2 antibody (Invitrogen, CB11) was used in immunohistochemistry on cat samples at 1:200 (fig 1c). Tumour Biol (2016) ncbi
mouse monoclonal (CB11)
  • western blot; human
In order to evaluate the role of leptin/STAT3 and HER2 receptor in tamoxifen resistance, Invitrogen ERBB2 antibody (Thermo Fisher Scientific, MS-441-S) was used in western blot on human samples . Cell Oncol (Dordr) (2015) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry; human; 1:600
In order to evaluate the prevalence, characteristics, prognosis, and effective treatment modalities in patients with primary squamous cell carcinoma of the breast, Invitrogen ERBB2 antibody (Zymed, CB11) was used in immunohistochemistry on human samples at 1:600. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to use Contrast-enhanced computer technology to display prognostic significance in breast cancer, Invitrogen ERBB2 antibody (Invitrogen, CB11) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). BMC Cancer (2014) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to study BRAC1-deficiency in sporadic breast cancer, Invitrogen ERBB2 antibody (Life Technologies, CB11) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Tumour Biol (2013) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry - paraffin section; human; 1:600; fig 2
In order to study triple negative breast cancer in Chinese women, Invitrogen ERBB2 antibody (Zymed, clone CB11) was used in immunohistochemistry - paraffin section on human samples at 1:600 (fig 2). Int J Clin Exp Pathol (2013) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry; human; fig 3
In order to report the case of primary acinic cell carcinoma of the breast in a 38-year-old woman, Invitrogen ERBB2 antibody (Zymed, CB11) was used in immunohistochemistry on human samples (fig 3). Int J Surg Pathol (2014) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry - paraffin section; human; fig 2
In order to investigate prognostic or predictive biomarkers of breast cancer, Invitrogen ERBB2 antibody (Life Technologies, Clone CB11) was used in immunohistochemistry - paraffin section on human samples (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (CB11)
  • western blot; human; fig 2a
In order to study the importance of survivin to HER2(+) breast cancer radioresistance, Invitrogen ERBB2 antibody (Thermo Fisher Scientific, MS-441-S) was used in western blot on human samples (fig 2a). J Cell Mol Med (2011) ncbi
mouse monoclonal (CB11)
  • immunohistochemistry - paraffin section; human; 1:3
In order to discuss features used to classify pure mucinous carcinomas of the breast, Invitrogen ERBB2 antibody (Zymed, CB11) was used in immunohistochemistry - paraffin section on human samples at 1:3. Cancer (2002) ncbi
Abcam
rabbit monoclonal (SP101)
  • immunocytochemistry; scFv; 1:100; loading ...; tbl 1
Abcam ERBB2 antibody (abcam, ab135376) was used in immunocytochemistry on scFv samples at 1:100 (tbl 1). PLoS ONE (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (7F8)
  • western blot; mouse; 1:500; fig 2
In order to study the alterations of brain Neuregulin-1 signaling during neuroinflammation, Santa Cruz Biotechnology ERBB2 antibody (Santa Cruz, sc-81508) was used in western blot on mouse samples at 1:500 (fig 2). Mol Med Rep (2016) ncbi
Articles Reviewed
  1. Jeong J, Kim W, Kim L, VanHouten J, Wysolmerski J. HER2 signaling regulates HER2 localization and membrane retention. PLoS ONE. 2017;12:e0174849 pubmed publisher
  2. Jeong J, VanHouten J, Kim W, Dann P, Sullivan C, Choi J, et al. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2. J Biol Chem. 2017;292:6555-6568 pubmed publisher
  3. Gomes de Castro M, Hobartner C, Opazo F. Aptamers provide superior stainings of cellular receptors studied under super-resolution microscopy. PLoS ONE. 2017;12:e0173050 pubmed publisher
  4. Yang Z, Jiang Q, Chen S, Hu C, Shen H, Huang P, et al. Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model. Mol Med Rep. 2016;14:790-6 pubmed publisher
  5. Soares M, Ribeiro R, Najmudin S, Gameiro A, Rodrigues R, Cardoso F, et al. Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status. Oncotarget. 2016;7:17314-26 pubmed publisher
  6. Li H, Shen P, Liang Y, Zhang F. Fibroblastic reticular cell tumor of the breast: A case report and review of the literature. Exp Ther Med. 2016;11:561-564 pubmed
  7. Jeong J, VanHouten J, Dann P, Kim W, Sullivan C, Yu H, et al. PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer. Proc Natl Acad Sci U S A. 2016;113:E282-90 pubmed publisher
  8. Liu X, Feng C, Liu J, Zhao L, Liu J, Zhang W, et al. Heat shock protein 27 and gross cystic disease fluid protein 15 play critical roles in molecular apocrine breast cancer. Tumour Biol. 2016;37:8027-36 pubmed publisher
  9. Soares M, Correia J, Peleteiro M, Ferreira F. St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study. Tumour Biol. 2016;37:4053-64 pubmed publisher
  10. Papanikolaou V, Stefanou N, Dubos S, Papathanasiou I, Palianopoulou M, Valiakou V, et al. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes. Cell Oncol (Dordr). 2015;38:155-64 pubmed publisher
  11. Liu J, Yu Y, Sun J, He S, Wang X, Yin J, et al. Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast. Breast Cancer Res Treat. 2015;149:133-40 pubmed publisher
  12. Li J, Zhang Y, Zhang W, Gao Y, Jia S, Guo J. Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer. BMC Cancer. 2014;14:672 pubmed publisher
  13. Ren J, Jin F, Yu Z, Zhao L, Wang L, Bai X, et al. MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency. Tumour Biol. 2013;34:3945-58 pubmed publisher
  14. Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. Int J Clin Exp Pathol. 2013;6:1380-91 pubmed
  15. Zhao Y, Li W, Lang R, Yang Y, Gao X, Zheng Y, et al. Primary acinic cell carcinoma of the breast: a case report and review of the literature. Int J Surg Pathol. 2014;22:177-81 pubmed publisher
  16. Pereira C, Leal M, de Souza C, Montenegro R, Rey J, Carvalho A, et al. Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy. PLoS ONE. 2013;8:e60576 pubmed publisher
  17. Papanikolaou V, Iliopoulos D, Dimou I, Dubos S, Kappas C, Kitsiou Tzeli S, et al. Survivin regulation by HER2 through NF-?B and c-myc in irradiated breast cancer cells. J Cell Mol Med. 2011;15:1542-50 pubmed publisher
  18. Ng W. Fine-needle aspiration cytology findings of an uncommon micropapillary variant of pure mucinous carcinoma of the breast: review of patients over an 8-year period. Cancer. 2002;96:280-8 pubmed